Company Filing History:
1 out of 38 
1 out of 6 
1 out of 8 Years Active: 2019
Title: Ariadna Bargiela Schönbrunn: Innovator in Myotonic Dystrophy Treatment
Introduction
Ariadna Bargiela Schönbrunn is a notable inventor based in València, Spain. She has made significant contributions to the field of medical research, particularly in the treatment of myotonic dystrophy. Her innovative work has led to the development of a unique compound aimed at addressing this challenging condition.
Latest Patents
Ariadna holds a patent for "Compounds for the treatment of myotonic dystrophy." This invention relates to a compound of formula (I), which is not caffeine, intended for use in treating myotonic dystrophy types 1 and 2. The patent also encompasses compositions that include this compound and introduces new compounds that are dimers of the original formula.
Career Highlights
Throughout her career, Ariadna has been associated with prestigious institutions such as Universitat de València and Institut Químic de Sarria CETS Fundació Privada. Her work in these organizations has been instrumental in advancing research in her field.
Collaborations
Ariadna has collaborated with notable colleagues, including Ruben Artero Allepuz and Josep Castells Boliart. These partnerships have enriched her research and contributed to her innovative projects.
Conclusion
Ariadna Bargiela Schönbrunn is a pioneering inventor whose work in developing treatments for myotonic dystrophy showcases her dedication to medical innovation. Her contributions are vital in the ongoing quest to improve the lives of those affected by this condition.